Showing 1 - 10 of 97
We study size and growth distributions of products and business firms in the context of a given industry. Firm size growth is analyzed in terms of two basic mechanisms, i.e. the increase of the number of new elementary business units and their size growth. We find a power-law relationship...
Persistent link: https://www.econbiz.de/10005020505
Since Comanor and Scherer (1969), researchers have been using patents as a proxy for new product development. In this paper, we reevaluate this relationship by using novel new data. We demonstrate that the relationship between patenting and new FDA-approved product introductions has diminished...
Persistent link: https://www.econbiz.de/10005790197
In 1970 the USA spent 7% of its GNP on healthcare, in 200716%. Whereas the OECD average per capita expenditure on healthcare in 2007 was $2,964, the USA spent $7,290. Yet in that same period, the health of America’s citizens relative to those of other developed countries declined dramatically,...
Persistent link: https://www.econbiz.de/10008544705
The study tests the FDI spillover hypothesis in the Indian Pharmaceutical industry using an unbalanced panel data for a sample of firms over the period 1989-90 to 2000-01. The study estimates firm-specific productive efficiency growth for domestic firms from frontier production function and...
Persistent link: https://www.econbiz.de/10005059093
measures that are affecting demand for pharmaceuticals in all major markets. This Perspective considers the impact of the … has spawned cost containment policies that are restricting the demand for drugs in all major markets. This Perspective …
Persistent link: https://www.econbiz.de/10005109573
, which covers both elementary units (products) and classes (markets, firms) in a given industry (pharmaceuticals), covering …
Persistent link: https://www.econbiz.de/10005031401
We study the betweenness centrality of fractal and non-fractal scale-free network models as well as real networks. We show that the correlation between degree and betweenness centrality C of nodes is much weaker in fractal network models compared to non-fractal models. We also show that nodes of...
Persistent link: https://www.econbiz.de/10005031411
position of the US as a locus of innovation in pharmaceuticals has increased over the past decade compared to Europe. All in … in pharmaceuticals: 1) The size and the structure of the biomedical education and research systems; 2) Some basic …
Persistent link: https://www.econbiz.de/10005034968
This paper tries to address the extent, nature and impact of the recent surge in consolidation strategies especially in the form of mergers and acquisitions followed by the firms in the Indian pharmaceutical industry. The study found that many of the firms are implementing these strategies in...
Persistent link: https://www.econbiz.de/10005620025
This study assesses the market structure and competitiveness of Malaysian pharmaceutical industry. A panel analysis of 41 pharmaceutical manufacturing firms over 2004-2012 is conducted founded on the modified Structure-Conduct-Performance (SCP) framework. Our study reveals that the Malaysian...
Persistent link: https://www.econbiz.de/10011107532